Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...

They left basic science and went into medicine ... The U.S. Department of Health and Human Services is also winding down mRNA vaccine development research under Health Secretary Robert F. Kennedy, who ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

The 54th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 2025), was held from June 15–19, 2025, in Bruges, Belgium. This “Column Watch” installment ...

For the past 20 years, the University of Notre Dame has sponsored a yearlong dialogue on a given theme, with featured speakers, panels and other public events at which the year’s theme is discussed ...

Many who talk about stopping pandemics focus on more labs or faster vaccines, but a new report demonstrates that high inequality is fuelling pandemics and increasing vulnerability.

Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.